Reepithelialization of orthotopic tracheal allografts prevents rejection after withdrawal of immunosuppression

Annals of Otology, Rhinology and Laryngology

Volumn 114, Issue 4, 2005, Pages 279-288

  Govindaraj, Satish ^a   Fedorova, Elena ^a   Genden, Eric M ^a   Chaboki, Houtan ^a   Bromberg, Jonathan S ^a   Cleven, Heidi ^a   Mayer, Lloyd ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Immunosuppression withdrawal; Rejection; Trachea; Transplant

Indexed keywords

CYCLOSPORIN A;

ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CILIATED EPITHELIUM; CONTROLLED STUDY; ELECTRON MICROSCOPY; EPITHELIZATION; GRAFT REJECTION; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; LAMINA PROPRIA; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; ORGAN TRANSPLANTATION; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL; TRACHEA; TRACHEA GRAFT; TREATMENT WITHDRAWAL;

EID: 17244380610     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940511400406     Document Type: Article

References (26)

1. Genden EM, Cannon PJ, Smith S, Keck N, Deftereos M, Urken ML. Microvascular transfer of long tracheal autograft segments in the canine model. Laryngoscope 2002; 112:439-44.
2. Strome M, Stein J, Esclamado R, et al. Laryngeal transplantation and 40-month follow-up. N Engl J Med 2001;344:1676-9.
3. Genden EM, Boros P, Liu J, Bromberg JS, Mayer L. Orthotopic tracheal transplantation in the murine model. Transplantation 2002;73:1420-5.
4. Beigel A, Muller-Ruchholtz W. Tracheal transplantation. I. The immunogenic effect of rat tracheal transplants. Arch Otorhinolaryngol 1984;240:185-92.
5. Ikonen TS, Brazelton TR, Berry GJ, Shorthouse RS, Morris RE. Epithelial re-growth is associated with inhibition of obliterative airway disease in orthotopic tracheal allografts in non-immunosuppressed rats. Transplantation 2000;70:857-63.
6. Hricik DE, O'Toole MA, Schulak JA, Herson J. Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients: a meta-analysis. J Am Soc Nephrol 1993;4:1300-5.
7. Devlin J, Doherty D, Thomson L, et al. Defining the outcome of immunosuppression withdrawal after liver transplantation. Hepatology 1998;27:926-33.
8. Hricik DE, Lautman J, Bartucci MR, Moir EJ, Mayes JT, Schulak JA. Variable effects of steroid withdrawal on blood pressure reduction in cyclosporine-treated renal transplant recipients. Transplantation 1992;53:1232-5.
9. Starzl TE, Demetris AJ, Murase N, Ildstad S, Ricordi C, Trucco M. Cell migration, chimerism, and graft acceptance. Lancet 1992;339:1579-82.
10. Corry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 1973;16:343-50.
11. Dosanjh A, Wan B, Ikonen T, Boeke K, Morris RE. Airway goblet cells and respiratory epithelial injury in an animal model of obliterative airways disease (OAD). Am J Transplant 2001;1:321-4.
12. Genden EM, Iskander AJ, Bromberg JS, Mayer L. Orthotopic tracheal allografts undergo reepithelialization with recipient-derived epithelium. Arch Otolaryngol Head Neck Surg 2003;129:118-23.
13. Millan MT, Shizuru JA, Hoffmann P, et al. Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation. Transplantation 2002;73:1386-91.
14. Neuringer IP, Mannon RB, Coffman TM, et al. Immune cells in a mouse airway model of obliterative bronchiolitis. Am J Respir Cell Mol Biol 1998;19:379-86.
15. Shirasugi N, Adams AB, Durham MM, et al. Prevention of chronic rejection in murine cardiac allografts: a comparison of chimerism- and nonchimerism-inducing costimulation blockade-based tolerance induction regimens. J Immunol 2002;169:2677-84.
16. Shirasugi N, Akiyama Y, Ikeda Y, et al. Intratracheal delivery of alloantigen induces donor-specific hyporesponsiveness: dendritic cells play a pivotal role as regulatory cells. Transplant Proc 2001;33:86.
17. Akiyama Y, Shirasugi N, Aramaki O, et al. Intratracheal delivery of a single major histocompatibility complex class I peptide induced prolonged survival of fully allogeneic cardiac grafts and generated regulatory cells. Hum Immunol 2002;63:888-92.
18. Naidu B, Krishnadasan B, Whyte RI, Warner RL, Ward PA, Mulligan MS. Regulatory role of IL-10 in experimental obliterative bronchiolitis in rats. Exp Mol Pathol 2002;73:164-70.
19. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989;170:2081-95.
20. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991;147:3815-22.
21. Mulligan MS, Jones ML, Vaporciyan AA, Howard MC, Ward PA. Protective effects of IL-4 and IL-10 against immune complex-induced lung injury. J Immunol 1993;151:5666-74.
22. Boehler A, Chamberlain D, Xing Z, et al. Adenovirusmediated interleukin-10 gene transfer inhibits post-transplant fibrous airway obliteration in an animal model of bronchiolitis obliterans. Hum Gene Ther 1998;9:541-51.
23. Hricik DE. Withdrawal of immunosuppression: implications for composite tissue allograft transplantation. Transplant Proc 1998;30:2721-3.
24. Fuchimoto Y, Yamada K, Shimizu A, et al. Relationship between chimerism and tolerance in a kidney transplantation model. J Immunol 1999;162:5704-11.
25. Mazariegos GV, Reyes J, Marino IR, et al. Weaning of immunosuppression in liver transplant recipients. Transplantation 1997;63:243-9.
26. Starzl TE, Demetris AJ, Trucco M, et al. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology 1993;17:1127-52.